New Insights into the Interaction between Graphene Oxide and Beta-Blockers

被引：4
|
作者：
Deng, Yuehua [1 ,2 ]
Li, Yani [1 ,2 ]
Nie, Wenjie [1 ,2 ]
Gao, Xiang [1 ,2 ]
Liu, Shentan [1 ,2 ]
Tan, Xiaochun [1 ]
Chen, Mingming [1 ]
Hou, Dongzhuang [1 ,2 ]
机构：
[1] Xian Univ Sci & Technol, Coll Geol & Environm, Xian 710054, Shaanxi, Peoples R China
[2] Shaanxi Prov Key Lab Geol Support Coal Green Expl, Xian 710054, Shaanxi, Peoples R China
来源：
NANOMATERIALS | 2019年 / 9卷 / 10期
关键词：
magnetic graphene oxide; propranolol; Fe3O4; adsorption; HEAVY-METAL IONS; AQUEOUS-SOLUTION; FACILE SYNTHESIS; ADSORPTION; REMOVAL; ADSORBENT; PHARMACEUTICALS; NANOMATERIALS; PROPRANOLOL; MECHANISM;
D O I：
10.3390/nano9101429
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
As a nano-adsorbent, magnetic graphene oxide (GO/Fe3O4) was synthesized to potentially adsorb propranolol (PRO) from water. The synthetic material was characterized by SEM, TEM, VSM, FTIR, XRD, zeta potential, and XPS. The environmental factors, such as pH, humic acid concentration, PRO concentration, and contact time, were investigated regarding their effect on the adsorption process. The kinetics data fitted the pseudo first-order and second-order kinetics equations. The Langmuir equation, the Freundlich equation, and the Sips equation were used to analyze the adsorption isotherms. Electrostatic attraction, hydrogen bonding, and the pi-pi interaction all contributed to the adsorption process of PRO onto GO/Fe3O4. The discovery of this study emphasized the feasibility of GO/Fe3O4 removal of PRO and expanded the scope of the application of GO.
引用
收藏
页数：18
相关论文
共 50 条
  • [21] BETA-BLOCKERS
    BERTRAND, ME
    LABLANCHE, JM
    GAZETTE MEDICALE DE FRANCE, 1979, 86 (12): : 1233 - &
  • [22] NEW DRUGS - BETA-BLOCKERS AND SYMPATHOMIMETICS
    KAYE, CM
    BRITISH MEDICAL JOURNAL, 1983, 286 (6375): : 1439 - 1439
  • [23] THE BETA-BLOCKERS
    GIUDICELLI, JF
    WITCHITZ, S
    SEMAINE DES HOPITAUX, 1983, 59 (34): : 2395 - 2426
  • [24] BETA-BLOCKERS
    LOUIS, WJ
    LOUIS, SN
    KRUM, H
    MEDICAL JOURNAL OF AUSTRALIA, 1994, 161 (09) : 555 - 557
  • [25] PHARMACODYNAMIC INTERACTION BETWEEN BETA-BLOCKERS AND VERAPAMIL - POSSIBLE RELEVANCE OF ANCILLARY PROPERTIES
    CARRUTHERS, SG
    FREEMAN, DJ
    BAILEY, DG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 170 - 170
  • [26] UNFAVORABLE INTERACTIONS BETWEEN NIFEDIPINE AND BETA-BLOCKERS
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1981, 59 (06): : 169 - 169
  • [27] Effects of vasodilatory beta-blockers on nitric oxide release
    Hayakawa, H
    Hirata, Y
    Kakoki, M
    Nishimatsu, H
    Suzuki, Y
    Nagata, D
    Suzuki, E
    Kimura, K
    Goto, A
    Omata, M
    JOURNAL OF HYPERTENSION, 1998, 16 : S91 - S91
  • [28] Effects of vasodilators beta-blockers on nitric oxide release
    Kakoki, M
    Hirata, Y
    Hayakawa, H
    Nishimatsu, H
    Suzuki, Y
    Nagata, D
    Suzuki, E
    Kimura, K
    Goto, A
    Omata, M
    HYPERTENSION, 1998, 32 (03) : 632 - 632
  • [29] THE INTERACTION OF ALCOHOL AND BETA-BLOCKERS IN ARTERIAL-HYPERTENSION
    MAHESWARAN, R
    BEEVERS, DG
    KENDALL, MJ
    DAVIES, P
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1990, 15 (06) : 405 - 410
  • [30] New arguments in favour of cardioselective beta-blockers
    Cleophas, TJM
    Kalmansohn, RB
    NETHERLANDS JOURNAL OF MEDICINE, 1995, 47 (06): : 308 - 310
12345